These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7179827)

  • 21. [Formation and specific activity of the adrenalin-heparin complex in human blood].
    Kudriashov BA; Podol'skaia OV; Liapina LA
    Kardiologiia; 1971 Jul; 11(7):105-8. PubMed ID: 5130674
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heparin-histamine complex, its physico-chemical and biological properties].
    Kudriashov BA; Liapina LA; Azieva LD
    Vopr Med Khim; 1990; 36(4):55-7. PubMed ID: 2238534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of the duration of action of heparin--thromboplastin complex in the bodies of animals maintained on natural and atherogenic diets].
    Liapina LA; Bazaz'ian GG
    Vopr Med Khim; 1981; 27(1):115-20. PubMed ID: 7467198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Heparin and chemically related compounds. Study in experimental thrombosis].
    Vairel EG; Brouty-Boyé H; Toulemonde F; Doutremepuich C
    Ann Pharm Fr; 1983; 41(5):421-5. PubMed ID: 6675504
    [No Abstract]   [Full Text] [Related]  

  • 25. [The molecular mechanism of the fibrinogen--heparin complex formation reaction].
    Rozenfel'd MA; Erzinkain KL; Piruzian LA
    Izv Akad Nauk SSSR Biol; 1975; (3):419-27. PubMed ID: 1214026
    [No Abstract]   [Full Text] [Related]  

  • 26. [On simplex formation with heparin of the kallikrein inhibitor from bovine organs].
    Kraut H; Bhargava N
    Hoppe Seylers Z Physiol Chem; 1967 Nov; 348(11):1502-4. PubMed ID: 5300804
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complex formation reaction between heparin and fibrinogen in normal subjects and in disease].
    Erzinkian KL; Titova MI; Rozenfel'd MA; Shimkevich LL; Piruzian LA
    Izv Akad Nauk SSSR Biol; 1978; (5):717-22. PubMed ID: 711985
    [No Abstract]   [Full Text] [Related]  

  • 28. Heparin compromises streptokinase-induced arterial patency in rabbits.
    Vlasin M; Rak J; Weitz JI; Peng L; Gumulec J; Johnston M; Klement P
    Thromb Res; 2005; 115(5):427-34. PubMed ID: 15733977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of ACTH in the formation of heparin complexes in blood under immobilization stress conditions].
    Kudrjashov BA; Shapiro FB; Lomovskaja EG; Liapina LA
    Thromb Res; 1975 Aug; 7(2):285-95. PubMed ID: 169603
    [No Abstract]   [Full Text] [Related]  

  • 30. [Heparin and fibrinolysis inhibitors].
    Villaverde CA; Badimón L; Vidal M; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):97-100. PubMed ID: 7325724
    [No Abstract]   [Full Text] [Related]  

  • 31. [State of the thromboforming properties of the blood in panarteritis of the aorta].
    Nikolaeva LF; Abugova SP
    Kardiologiia; 1969 May; 9(5):100-3. PubMed ID: 4389967
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of sodium heparin on activated fibrinolysis in the rat in vivo].
    Badimón L; Villaverde C; Badimón JJ; Vidal M; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):105-8. PubMed ID: 7325697
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study of silylated heparin and sodium heparinate].
    Shchelkova TV; Kazimirovskaia VB; Liapina LA; Voronkov MG
    Vopr Med Khim; 1985; 31(3):87-9. PubMed ID: 4024537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood coagulation in rheumatic heart disease according to the data of a thromboelastographic study].
    Pinkus SSh
    Kardiologiia; 1967 Dec; 7(12):112-7. PubMed ID: 5303820
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the effect of E-aminocaproic acid on the permeability of capillary vessels].
    Dzizinskiĭ AA; Kochergina TK; Seregina NM
    Farmakol Toksikol; 1968; 31(4):425-6. PubMed ID: 5698132
    [No Abstract]   [Full Text] [Related]  

  • 36. [Influence of ellagic acid and heparin on coagulation, fibrinolysis and metastasis in traumatized animals (author's transl)].
    Agostino D; Agostino N
    Sangre (Barc); 1980; 25(6):989-98. PubMed ID: 7221832
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ancrod: understanding the agent.
    Illig KA; Ouriel K
    Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention of experimental thrombogenesis with secondary adrenaline-heparin-fibrinogen complex].
    Kudriashov BA; Liapina LA; Shitnikova ES; Ul'ianova AM
    Kardiologiia; 1977 Aug; 17(8):127-30. PubMed ID: 926556
    [No Abstract]   [Full Text] [Related]  

  • 40. [Heparin-trypsin complex and its effect on blood fibrinolytic properties in vitro and in vivo].
    Kudriashov BA; Klishevskaia TM; Bazaz'ian GG; Poliakova LA
    Vopr Med Khim; 1965; 11(3):45-52. PubMed ID: 5867957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.